Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Current Value
$319.841 Year Return
Current Value
$319.841 Year Return
Market Cap
$8.98B
P/E Ratio
-11.73
1Y Stock Return
4.73%
1Y Revenue Growth
-5.15%
Dividend Yield
0.00%
Price to Book
1.2
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TMO | 60.56% | $194.74B | +5.54% | 0.30% |
DHR | 56.02% | $166.73B | +5.96% | 0.46% |
RVTY | 55.94% | $13.38B | +23.61% | 0.26% |
RGEN | 54.01% | $7.20B | -18.16% | 0.00% |
TECH | 52.96% | $10.55B | +4.49% | 0.48% |
A | 52.36% | $36.11B | +1.43% | 0.75% |
WAT | 51.16% | $20.47B | +25.51% | 0.00% |
MTD | 48.93% | $24.49B | +6.92% | 0.00% |
ILMN | 47.57% | $21.41B | +44.38% | 0.00% |
AVTR | 47.10% | $13.42B | -0.40% | 0.00% |
QGEN | 45.36% | $9.05B | -1.92% | 0.00% |
KFRC | 45.18% | $1.10B | -8.71% | 0.66% |
MIDD | 44.06% | $7.33B | +10.42% | 0.00% |
AZTA | 44.02% | $2.00B | -28.24% | 0.00% |
IQV | 43.64% | $34.73B | -7.77% | 0.00% |
LAD | 43.02% | $9.87B | +38.08% | 0.56% |
STHO | 42.57% | $150.51M | -5.99% | 0.00% |
ETD | 42.56% | $740.01M | +7.77% | 5.25% |
ECPG | 42.50% | $1.15B | +10.73% | 0.00% |
CYRX | 42.37% | $342.80M | -48.82% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CPSH | 0.03% | $20.70M | -40.13% | 0.00% |
EFR | 0.03% | $1.42B | -14.34% | 0.00% |
PRPO | -0.06% | $9.10M | -13.65% | 0.00% |
ARLP | -0.09% | $3.54B | +26.77% | 10.11% |
EVER | -0.09% | $664.25M | +124.76% | 0.00% |
MBI | -0.09% | $335.78M | +105.79% | 0.00% |
SU | 0.10% | $52.05B | +23.58% | 3.92% |
PBR | -0.12% | $52.88B | -8.22% | 5.68% |
UFI | 0.13% | $102.66M | -11.22% | 0.00% |
UTI | 0.15% | $1.07B | +73.54% | 0.00% |
LPLA | -0.18% | $23.55B | +38.13% | 0.38% |
SCKT | 0.18% | $10.88M | +15.32% | 0.00% |
CRVO | -0.19% | $83.20M | +2.86% | 0.00% |
CREG | 0.21% | $6.14M | -35.78% | 0.00% |
SPR | 0.21% | $3.72B | +23.27% | 0.00% |
JNPR | 0.22% | $11.61B | +30.55% | 2.49% |
BTCT | 0.22% | $42.61M | +353.33% | 0.00% |
PBT | 0.22% | $606.38M | -27.11% | 5.87% |
CMTL | 0.23% | $84.44M | -76.16% | 0.00% |
TEN | 0.27% | $606.64M | +3.32% | 4.39% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PULM | -16.34% | $19.83M | +202.98% | 0.00% |
HUSA | -14.46% | $16.69M | -11.56% | 0.00% |
MNR | -13.40% | $1.66B | -10.71% | 15.90% |
NNE | -12.28% | $833.66M | +531.50% | 0.00% |
VST | -12.27% | $52.69B | +349.00% | 0.56% |
CEG | -12.21% | $73.37B | +91.48% | 0.59% |
NHTC | -9.55% | $61.83M | +0.19% | 14.81% |
ALAR | -8.98% | $89.09M | +158.08% | 0.00% |
GEL | -8.22% | $1.44B | +2.81% | 5.24% |
HII | -7.97% | $7.50B | -19.92% | 2.70% |
ANIK | -7.28% | $249.56M | -17.52% | 0.00% |
QNRX | -6.82% | $3.20M | -85.07% | 0.00% |
VIST | -6.78% | $4.75B | +67.10% | 0.00% |
TPST | -6.22% | $37.75M | -77.59% | 0.00% |
OXBR | -6.19% | $19.05M | +178.18% | 0.00% |
FATBB | -5.99% | $81.94M | -12.91% | 11.69% |
VRN | -4.94% | $3.23B | -25.43% | 6.21% |
TCTM | -4.92% | $8.10M | -42.99% | 0.00% |
LUMO | -4.82% | $37.45M | +41.97% | 0.00% |
CYCN | -4.66% | $4.77M | -16.19% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPH | 59.05% | $885.96M | 0.4% |
FBT | 56.70% | $1.11B | 0.56% |
FXH | 55.91% | $1.15B | 0.62% |
FHLC | 53.99% | $2.73B | 0.084% |
VHT | 53.53% | $17.06B | 0.1% |
IBB | 53.40% | $6.66B | 0.45% |
PINK | 52.46% | $161.15M | 0.5% |
BBH | 52.39% | $397.87M | 0.35% |
MOAT | 51.83% | $15.73B | 0.46% |
IXJ | 51.37% | $3.89B | 0.41% |
IJH | 51.35% | $95.89B | 0.05% |
PBE | 51.15% | $258.53M | 0.58% |
GNOM | 50.87% | $70.59M | 0.5% |
IYH | 50.78% | $3.19B | 0.39% |
XLV | 50.42% | $38.41B | 0.09% |
SCHM | 50.00% | $11.59B | 0.04% |
VTV | 49.42% | $131.67B | 0.04% |
DSTL | 49.40% | $2.02B | 0.39% |
SCHV | 49.21% | $12.04B | 0.04% |
FSMD | 49.18% | $583.89M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JBBB | 0.01% | $1.26B | 0.49% |
CMDY | 0.12% | $279.14M | 0.28% |
FBY | 0.37% | $127.69M | 0.99% |
CORN | 0.48% | $61.12M | 0.2% |
GCC | -0.56% | $133.23M | 0.55% |
CSHI | 1.10% | $482.85M | 0.38% |
TPMN | -1.18% | $40.60M | 0.65% |
HDRO | -1.23% | $164.26M | 0.3% |
UNG | 1.25% | $908.80M | 1.06% |
FTGC | -1.37% | $2.17B | 1.02% |
TBIL | -1.62% | $4.38B | 0.15% |
ICLO | 1.82% | $209.30M | 0.2% |
BCD | -1.86% | $245.02M | 0.3% |
MINT | 2.28% | $11.62B | 0.35% |
CANE | 2.30% | $17.72M | 0.29% |
BCI | -2.56% | $1.20B | 0.26% |
SOYB | -2.61% | $27.32M | 0.22% |
FMF | 2.93% | $244.61M | 0.95% |
HIGH | -3.25% | $302.78M | 0.51% |
BOXX | -3.45% | $4.43B | 0.1949% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -29.21% | $388.04M | 1.43% |
USDU | -28.39% | $201.97M | 0.5% |
UUP | -25.95% | $309.25M | 0.77% |
CTA | -18.15% | $350.27M | 0.78% |
VIXY | -16.07% | $195.31M | 0.85% |
EQLS | -15.90% | $76.08M | 1% |
KMLM | -11.99% | $353.87M | 0.9% |
DBO | -11.73% | $217.57M | 0.77% |
CLOI | -10.56% | $715.40M | 0.4% |
COMT | -9.01% | $829.06M | 0.48% |
KRBN | -8.66% | $242.47M | 0.85% |
AGZD | -8.42% | $142.76M | 0.23% |
GSG | -8.06% | $914.42M | 0.75% |
PDBC | -7.28% | $4.40B | 0.59% |
TAIL | -6.41% | $67.98M | 0.59% |
WEAT | -6.34% | $120.27M | 0.28% |
DBE | -6.27% | $50.13M | 0.77% |
DBA | -5.94% | $755.88M | 0.93% |
DBC | -5.89% | $1.39B | 0.87% |
KCCA | -5.58% | $220.51M | 0.87% |
Yahoo
Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. Due to the economy’s resilience and forecasters’ expectations of a soft landing, all major U.S. indices enjoyed gains in the third quarter. In the third quarter, the fund returned +10.61%, outperforming the […]
SeekingAlpha
Despite some volatility towards the month's end, investor sentiment remained cautiously optimistic. Click here to read more.
SeekingAlpha
All major U.S. indices posted gains in the third quarter with the economy demonstrating resilience and forecasters anticipating a soft landing.
Yahoo
Examine the evolution of Bio-Rad's (BIO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Yahoo
Shareholders of Bio-Rad Laboratories, Inc. ( NYSE:BIO ) will be pleased this week, given that the stock price is up 15...
Yahoo
Bio-Rad Laboratories ( NYSE:BIO ) Third Quarter 2024 Results Key Financial Results Revenue: US$649.7m (up 2.8% from 3Q...
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.